DHINGRA, Kapil,HIGGINS, Brian,KOLINSKY, Kenneth,LEE, Richard J.,LESTINI, Brian,PACKMAN, Kathryn E.,SU, Fei
申请号：
MYPI 2013700258
公开号：
MY161288A
申请日:
2011.08.16
申请国别(地区):
MY
年份:
2017
代理人:
摘要：
The present invention relates to a combination therapy of propane-1-sulfonic acid {3-[5-(4- chloro-phenyl)-1H-pyrrolo [2,3-b] pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, or a pharmaceutically acceptable salt thereof, and an EGFR inhibitor for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer.
